3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
11
Carcinoma, Renal Cell
10
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Myelodysplastic Syndromes
4
Lung Neoplasms
4
Clear-cell metastatic renal cell carcinoma
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Leukemia, Myeloid, Acute
3
Histiocytoma, Malignant Fibrous
3
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Penile Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Glioblastoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Endometrioid
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Uveal Melanoma
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Interventions
Rituximab
9
venetoclax
7
ibrutinib
7
Cyclophosphamide
7
Mycophenolic Acid
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Sirolimus
4
zanubrutinib
3
pirtobrutinib
3
Peripheral Blood Stem Cell Transplantation
3
Dexamethasone
3
Cyclosporine
3
ixazomib
2
fludarabine
2
carfilzomib
2
acalabrutinib
2
Tacrolimus
2
Melphalan
2
Etoposide
2
Cyclosporins
2
Calcium Dobesilate
2
CT-P10
2
Busulfan
2
Bendamustine Hydrochloride
2
talquetamab
1
pembrolizumab
1
loncastuximab tesirine
1
brexucabtagene autoleucel
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
CTLA-4 Antigen
×
90 days
×
Clear all
No trials found.